These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16567806)

  • 1. Metal ion site engineering indicates a global toggle switch model for seven-transmembrane receptor activation.
    Elling CE; Frimurer TM; Gerlach LO; Jorgensen R; Holst B; Schwartz TW
    J Biol Chem; 2006 Jun; 281(25):17337-17346. PubMed ID: 16567806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seven-transmembrane receptors.
    Holst B; Nygaard R; Valentin-Hansen L; Bach A; Engelstoft MS; Petersen PS; Frimurer TM; Schwartz TW
    J Biol Chem; 2010 Feb; 285(6):3973-3985. PubMed ID: 19920139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the CXCR3 chemokine receptor through anchoring of a small molecule chelator ligand between TM-III, -IV, and -VI.
    Rosenkilde MM; Andersen MB; Nygaard R; Frimurer TM; Schwartz TW
    Mol Pharmacol; 2007 Mar; 71(3):930-41. PubMed ID: 17170198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial agonism through a zinc-Ion switch constructed between transmembrane domains III and VII in the tachykinin NK(1) receptor.
    Holst B; Elling CE; Schwartz TW
    Mol Pharmacol; 2000 Aug; 58(2):263-70. PubMed ID: 10908293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanism of 7TM receptor activation--a global toggle switch model.
    Schwartz TW; Frimurer TM; Holst B; Rosenkilde MM; Elling CE
    Annu Rev Pharmacol Toxicol; 2006; 46():481-519. PubMed ID: 16402913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of agonist site to metal-ion chelator site in the beta(2)-adrenergic receptor.
    Elling CE; Thirstrup K; Holst B; Schwartz TW
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12322-7. PubMed ID: 10535920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PheVI:09 (Phe6.44) as a sliding microswitch in seven-transmembrane (7TM) G protein-coupled receptor activation.
    Valentin-Hansen L; Holst B; Frimurer TM; Schwartz TW
    J Biol Chem; 2012 Dec; 287(52):43516-26. PubMed ID: 23135271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connectivity and orientation of the seven helical bundle in the tachykinin NK-1 receptor probed by zinc site engineering.
    Elling CE; Schwartz TW
    EMBO J; 1996 Nov; 15(22):6213-9. PubMed ID: 8947044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6.
    Ballesteros JA; Jensen AD; Liapakis G; Rasmussen SG; Shi L; Gether U; Javitch JA
    J Biol Chem; 2001 Aug; 276(31):29171-7. PubMed ID: 11375997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar structures and shared switch mechanisms of the beta2-adrenoceptor and the parathyroid hormone receptor. Zn(II) bridges between helices III and VI block activation.
    Sheikh SP; Vilardarga JP; Baranski TJ; Lichtarge O; Iiri T; Meng EC; Nissenson RA; Bourne HR
    J Biol Chem; 1999 Jun; 274(24):17033-41. PubMed ID: 10358054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved water-mediated hydrogen bond network between TM-I, -II, -VI, and -VII in 7TM receptor activation.
    Nygaard R; Valentin-Hansen L; Mokrosinski J; Frimurer TM; Schwartz TW
    J Biol Chem; 2010 Jun; 285(25):19625-36. PubMed ID: 20395291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The arginine of the DRY motif in transmembrane segment III functions as a balancing micro-switch in the activation of the β2-adrenergic receptor.
    Valentin-Hansen L; Groenen M; Nygaard R; Frimurer TM; Holliday ND; Schwartz TW
    J Biol Chem; 2012 Sep; 287(38):31973-82. PubMed ID: 22843684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism.
    Holst B; Mokrosinski J; Lang M; Brandt E; Nygaard R; Frimurer TM; Beck-Sickinger AG; Schwartz TW
    J Biol Chem; 2007 May; 282(21):15799-811. PubMed ID: 17371869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F.
    Sheikh SP; Zvyaga TA; Lichtarge O; Sakmar TP; Bourne HR
    Nature; 1996 Sep; 383(6598):347-50. PubMed ID: 8848049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an agonist-induced conformational change occurring adjacent to the ligand-binding pocket of the M(3) muscarinic acetylcholine receptor.
    Han SJ; Hamdan FF; Kim SK; Jacobson KA; Bloodworth LM; Li B; Wess J
    J Biol Chem; 2005 Oct; 280(41):34849-58. PubMed ID: 16093246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal ion-mediated agonism and agonist enhancement in melanocortin MC1 and MC4 receptors.
    Holst B; Elling CE; Schwartz TW
    J Biol Chem; 2002 Dec; 277(49):47662-70. PubMed ID: 12244039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of metal-ion sites as distance constraints in structural and functional analysis of 7TM receptors.
    Elling CE; Thirstrup K; Nielsen SM; Hjorth SA; Schwartz TW
    Fold Des; 1997; 2(4):S76-80. PubMed ID: 9269573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refinement of a homology model of the mu-opioid receptor using distance constraints from intrinsic and engineered zinc-binding sites.
    Fowler CB; Pogozheva ID; LeVine H; Mosberg HI
    Biochemistry; 2004 Jul; 43(27):8700-10. PubMed ID: 15236578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of transmembrane segment II in 7TM receptor activation.
    Benned-Jensen T; Rosenkilde MM
    Curr Mol Pharmacol; 2009 Jun; 2(2):140-8. PubMed ID: 20021454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.